Philippe Moreau, MD from the University Hospital of Nantes, Nantes, France gives an overview of a prospective comparison on PET-CT and MRI in multiple myeloma (MM). The primary endpoint of the trial (NCT01309334) was to compare MRI and PET-CT in regard to the number of bone lesions at diagnosis and the secondary endpoint was to look at the prognostic impact of both imaging techniques. According to Prof Moreau, both techniques are equally effective at identifying the number bone lesions and PET-CT was able to predict progression-free survival (PFS). Prof Moreau argues that PET-CT is a very important imaging technique.
Recorded at the Myeloma 2016 meeting held in Boston, MA.